| NMRA |
Neumora Therapeutics, Inc. Common Stock |
2024 |
Q4 |
2025-03-03 |
|
| OCUL |
Ocular Therapeutix, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| NABL |
N-able, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| STXS |
Stereotaxis, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| RC |
Ready Capital Corporation |
2024 |
Q4 |
2025-03-03 |
|
| GCT |
GigaCloud Technology Inc. |
2024 |
Q4 |
2025-03-03 |
|
| EKSO |
Ekso Bionics Holdings, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| MRCC |
Monroe Capital Corporation |
2024 |
Q4 |
2025-03-03 |
|
| EBS |
Emergent BioSolutions Inc. |
2024 |
Q4 |
2025-03-03 |
|
| RILY |
B. Riley Financial, Inc. - 6.50 |
2024 |
Q4 |
2025-03-03 |
|
| FTRE |
Fortrea Holdings Inc. |
2024 |
Q4 |
2025-03-03 |
|
| TDUP |
ThredUp Inc. |
2024 |
Q4 |
2025-03-03 |
|
| BDSX |
Biodesix, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| NOMD |
Nomad Foods Limited |
2024 |
Q4 |
2025-03-03 |
|
| SGRY |
Surgery Partners, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| SMR |
NuScale Power Corporation |
2024 |
Q4 |
2025-03-03 |
|
| CRC |
California Resources Corporation |
2024 |
Q4 |
2025-03-03 |
|
| MRSN |
Mersana Therapeutics, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| HSII |
Heidrick & Struggles International, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| RPAY |
Repay Holdings Corporation |
2024 |
Q4 |
2025-03-03 |
|
| SNDX |
Syndax Pharmaceuticals, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| AVDL |
Avadel Pharmaceuticals plc |
2024 |
Q4 |
2025-03-03 |
|
| ADMA |
ADMA Biologics, Inc. |
2024 |
Q4 |
2025-03-03 |
|
| CLMT |
Calumet Specialty Products Partners, L.P. |
2024 |
Q4 |
2025-02-28 |
|
| EOG |
EOG Resources, Inc. |
2024 |
Q4 |
2025-02-28 |
|